P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia

Haematologia

Volumn 29, Issue 3, 1998, Pages 181-193

  Guran S ^a   Bahce M ^a   Beyan, C ^a   Korkmaz, K ^a   Yalcin A ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic myeloid leukemia; p15INK4B; p16INK4A; p53; p57KIP2

Indexed keywords

CARRIER PROTEIN; CDKN1C PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2B; NUCLEAR PROTEIN; PROTEIN P16INK4A; PROTEIN P53; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CHRONIC MYELOID LEUKEMIA; GENETICS; HUMAN; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P57; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0032241020     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Haim, S., Mittelman, F., (Eds), in: Chronic Myeloid Leukemia in Cancer Cytogenetics, p. 33. Willey Liss Inc., New York (1995).
2. Guerrasio, A., Serra, A., Gottardi, E., Cilloni, D., Vischia, F., Parvis, G., Cilli, V., Saglio, G., Molecular events in chronic myeloid leukemia progression, Cancer 37, 2346 (1997).
3. Ruley, E. H., p53 and Response to Chemotherapy and Radiotherapy, in: Important Advances in Oncology, De Vita, V. T., Hellman, S., Rosenbeg, S. (Eds), p. 37. Lippincott-Raven, Philadelphia (1996).
4. Krusawa, M., Okabe, M., Kunjedo, Y., Miyazaki, T., P53 gene mutation in the chronic phase was not detected in the myeloid crisis of a chronic myelocytic leukemia case, Blood 23, 2750 (1994).
5. Imamura, J., Miyashi, I., Koeffler, P. H., P53 in hematologic malignancies, Blood 84, 2412 (1994).
6. Marx, J., How p53 suppresses cell growth, Science 262, 1644 (1993).
7. el-Deiry, D. W., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrel, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., Vogelstain, B., WAF1/CIP 1 is induced in p53-mediated G1 arrest and apopitosis, Cancer Res. 54, 1169 (1994).
8. Morgan, D. O., Principles of CDK regulation, Nature 374, 131 (1995).
9. Nurse, P., Ordering S phase and M phase in the cell cycle, Cell 79, 547 (1994).
10. Sherr, C. S., G1 phase progression: Cycling on cue, Cell 179, 551 (1994).
11. Hunter, T., Pines, J., Cyclins and cancer II: Cyclin D and CDK inhibitors come of age, Cell 79, 573 (1994).
12. Guan, K. L., Jenkins, C. W., Li, Y., Nicholas, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., Xiang, Y., Growth suppression by p18, p16(INK4/MTSI) and p14 (INK4B/MTS2)-related CDK6 inhibitor, correlates with wide-type pRb function, Genes. Dev. 8, 2939 (1994).
13. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution, Genes. Develop. 9, 639 (1995).
14. CIPI Cdk inhibitor family, is a candidate tumor suppressor gene, Genes. Develop. 9, 650 (1995).
15. Arlin, Z. A., Silver, R. T., Bennet, J. M., Blastic phase of chronic myeloid leukemia: a proposal for standardization of diagnostic and response criteria, Leukemia 4, 755 (1990).
16. Yunis, J. J., New chromosome techniques in the study of human neoplasia, Human Pathol. 12, 540 (1981).
17. Rao, P. H., Murty, V. V. V. S., Gaidano, G., Hauptschein, R., Dalla-Favera, R., Chaganti, R. S. K., Subregional localization of 20 single-copy loci to chromosome 6 by fluorescence in situ hybridization, Genomics 16, 426 (1993).
18. Sambrook, J., Fritsch, E. F., Maniatis, T., Molecular Cloning. Cold Spring Harbor Lab. Press, New York (1998).
19. Liu, L., Lassam, N. J., Slingerland, J. M., Bailey, D., Cole, D., Jenkins, R., Hogg, D., Germline p16 INK4A mutation and protein dysfunction in a family with inherited melanoma, Oncogene 11, 405 (1995).
20. Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P., Georgiev, G. P., A variation in the structure of the protein-coding region of human p53 gene, Gene 70, 245 (1988).
21. Lee, P. M., De Baun, M., Randhava, G., Reichard, B. A., Elledge, S. J., Feinberg, A. P., Low frequency of p57 mutation in Beckwith-Wiedemann Syndrome, Am. J. Hum. Genet. 61, 304 (1997).
22. Orita, M., Suzuki, Y., Sekiya, T., Hayashi, K., Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction, Genomics 5, 874 (1989).
23. Dreyling, H. M., Bohlaander, S. K., Adeyanju, M. O., Olopade, O. I., Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization, Cancer Res. 55, 984 (1995).
24. Matthew, S., Murty, V. V. V. S., Hunziker, W., Chaganti, R. S. K., Subregional mapping of 13 single copy genes on long arm of chromosome 12 by fluorescence in situ hybridization, Genomics 14, 775 (1992).
25. Hopman, A. H. N., van Hooren, E., van de Kaa, C. A., Vooijs, P. G. P., Ramaekers, F. C. S., Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinlly processed bladder cancers, Modern Pathol. 4, 503 (1991).
26. KIP2 in soft tissue sarcomas and Wilm's tumors, Cancer Res. 56, 1219 (1996).
27. KIP2 gene and its analysis in the G40I Wilm's tumor assay, Cancer Res. 56, 1214 (1996).
28. Ahujoa, H., Bar-Eli, D., Advani, S. H., Bechimal, S., Cline, M. J., Alterations in the p53 gene and the clonal evaluation of the blast crisis of CML, Proc. Natl Acad. Sci USA 86, 6783 (1989).
29. Levine, A. S., Momand, S., Finlay, A. C., The p53 tumor suppressor gene, Nature 351, 453 (1991).
30. Hollstein, M., Sidaransky, D., Vogelstain, B., Harris, C. C., P53 mutation in human cancers, Science 253, 49 (1991).
31. Lewin, B., Genes VI. Oxford University Press, New York (1997).
32. INK4A tumor suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia, Blood 85, 2013 (1995).
33. Sera, A., Gottardi, E., Ragione, F. D., Saglio, G., Achilla, I., Involvement of the CDKN2 gene in the athogenesis of lymphoid blast crisis of chronic myeloid leukemia, Br. J. Haematol. 91, 625 (1995).
34. Pollock, P. M., Pearson, J. V., Hayward, N. K., Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions, Genes, Chromosomes Cancer 15, 77 (1996).
35. KIP2 gene and its analysis in the G401 Wilm's tumor assay, Cancer Res. 56, 1214 (1996).
36. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution, Genes Dev. 9, 639 (1995).
37. KIP2, a structurally distinct member of the p21 Cdk inhibitory family is a candidate tumor suppressor gene, Genes Dev. 9, 650 (1995).
38. Seizinger, B. R., Klinger, H. P., Junien, C., Nakamura, Y., Le Bau, M., Cavenee, W., Emanuel, B., Ponder, B., Naylor, S., Mitelman, F., Louis, D., Menon, A., Newsham, I., Decker, J., Kaelbling, M., Henry, I., Deimling, A. V., Report of the committee on chromosome and gene loss in human neoplasia, Cytogenet. Cell Genet. 58, 1080 (1991).
39. Sait, S. N. J., Nowak, N. J., Singh-Kahlon, P., Weksberg, R., Squire, J., Shows, T. B., Higgins, M. J., Localization of Beckwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5, Genes, Chromosomes Cancer 11, 97 (1994).
40. Hoovers, J. M. N., Kalikin, L. M., Johnson, L. A., Alders, M., Redeker, B., Law, D. J., Blick, J., Steenman, M., Benedict, M., Wiegant, J., Lengauer, C., Taillon, Miller, P., Schlessinger, D., Edwards, M. C., Elledge, S. J., Ivens, A., Westervald, A., Little, P., Mannens, M., Feinberg, A. P., Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments, Proc. Natl Acad. Sci. USA 92, 12 456 (1995).